Serological biomarkers of joint tissue turnover predict tocilizumab response at baseline. September 1, 2014 J Clin Rheumatol Go to full publication ADULTANTIBODIES, MONOCLONAL, HUMANIZEDARTHRITIS, RHEUMATOIDBIOMARKERS+12 Read publication